Acute viscerotropic disease following vaccination against yellow fever.
Acute viscerotropic disease following yellow fever vaccination (YEL-AVD) is a rare but serious complication of vaccination with 17D yellow fever vaccine. This paper reviews the existing literature regarding YEL-AVD and discusses possible etiologic mechanisms. A greater understanding of this condition is essential to assuring safe and effective prevention of yellow fever and vaccination against other arboviral diseases for which 17D-based vaccines are being developed.
Hayes
Edward B
EB
Arboviral Diseases Branch, Division of Vector-Borne Infectious Diseases, Centers for Disease Control and Prevention, Fort Collins, CO 80522, USA. ebh2@cdc.gov
D000208:Acute Disease; D005334:Fever / Q000209:etiology* / Q000235:genetics / Q000276:immunology; D006801:Humans; D009102:Multiple Organ Failure / Q000209:etiology* / Q000235:genetics / Q000276:immunology; D016896:Treatment Outcome; D015004:Yellow Fever / Q000517:prevention & control*; D022341:Yellow Fever Vaccine / Q000009:adverse effects* / Q000235:genetics / Q000276:immunology
D022341:Yellow Fever Vaccine